Zacks Research Issues Pessimistic Outlook for MC Earnings

Moelis & Company (NYSE:MC) – Investment analysts at Zacks Research cut their Q4 2024 earnings per share estimates for Moelis & Company in a research note issued on Wednesday, October 23rd. Zacks Research analyst R. Department now anticipates that the asset manager will post earnings per share of $0.36 for the quarter, down from their previous estimate of $0.43. The consensus estimate for Moelis & Company’s current full-year earnings is $0.98 per share. Zacks Research also issued estimates for Moelis & Company’s Q1 2025 earnings at $0.46 EPS, Q2 2025 earnings at $0.48 EPS, Q3 2025 earnings at $0.77 EPS and FY2026 earnings at $3.46 EPS.

Moelis & Company (NYSE:MC) last announced its quarterly earnings results on Wednesday, October 23rd. The asset manager reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. The company had revenue of $273.76 million during the quarter, compared to analysts’ expectations of $273.58 million. Moelis & Company had a return on equity of 4.38% and a net margin of 1.38%. Moelis & Company’s quarterly revenue was up .6% on a year-over-year basis. During the same period last year, the business earned ($0.15) earnings per share.

Other analysts have also recently issued reports about the company. Wells Fargo & Company began coverage on Moelis & Company in a research report on Thursday, September 12th. They issued an “equal weight” rating and a $70.00 price objective for the company. Keefe, Bruyette & Woods restated a “market perform” rating and issued a $60.00 price objective (up from $54.00) on shares of Moelis & Company in a research report on Thursday, July 25th. Morgan Stanley cut their price objective on Moelis & Company from $67.00 to $66.00 and set an “underweight” rating for the company in a research report on Thursday. JPMorgan Chase & Co. boosted their price objective on Moelis & Company from $50.00 to $51.00 and gave the company a “neutral” rating in a research report on Thursday, July 25th. Finally, UBS Group boosted their price objective on Moelis & Company from $54.00 to $60.00 and gave the company a “sell” rating in a research report on Tuesday, October 8th. Two analysts have rated the stock with a sell rating and six have issued a hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $60.83.

Moelis & Company Trading Down 1.6 %

Shares of MC stock opened at $65.89 on Thursday. The stock has a market cap of $4.93 billion, a P/E ratio of 439.27 and a beta of 1.33. Moelis & Company has a twelve month low of $39.08 and a twelve month high of $72.80. The stock has a 50 day moving average of $67.53 and a 200 day moving average of $60.69.

Moelis & Company Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Monday, November 4th will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 3.64%. The ex-dividend date is Monday, November 4th. Moelis & Company’s payout ratio is 1,600.00%.

Insider Buying and Selling

In other Moelis & Company news, CEO Kenneth Moelis sold 5,308 shares of the business’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $68.87, for a total transaction of $365,561.96. Following the transaction, the chief executive officer now owns 86 shares of the company’s stock, valued at approximately $5,922.82. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, CEO Kenneth Moelis sold 5,308 shares of the company’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $68.87, for a total value of $365,561.96. Following the transaction, the chief executive officer now owns 86 shares of the company’s stock, valued at $5,922.82. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kenneth Shropshire sold 495 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $69.29, for a total value of $34,298.55. Following the completion of the transaction, the director now directly owns 9,372 shares in the company, valued at approximately $649,385.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 6.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Moelis & Company

Several large investors have recently modified their holdings of the business. Diversify Wealth Management LLC lifted its stake in shares of Moelis & Company by 11.5% in the 3rd quarter. Diversify Wealth Management LLC now owns 29,756 shares of the asset manager’s stock valued at $2,031,000 after purchasing an additional 3,062 shares during the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of Moelis & Company by 108.1% in the 3rd quarter. Nisa Investment Advisors LLC now owns 4,043 shares of the asset manager’s stock valued at $277,000 after buying an additional 2,100 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Moelis & Company by 6.2% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 143,741 shares of the asset manager’s stock valued at $9,848,000 after buying an additional 8,342 shares during the period. Mount Yale Investment Advisors LLC purchased a new stake in Moelis & Company during the 3rd quarter worth about $185,000. Finally, Assenagon Asset Management S.A. purchased a new stake in Moelis & Company during the 3rd quarter worth about $49,017,000. Institutional investors and hedge funds own 91.53% of the company’s stock.

About Moelis & Company

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.